Evidence map›Paper›PMID 21028924›Full record

ArticleIET systems biology2009

Sensitivity analysis predicts that the ERK-pMEK interaction regulates ERK nuclear translocation.

K Radhakrishnan, J S Edwards, D S Lidke, T M Jovin, B S Wilson, J M Oliver

Open access · greenAbstract read
In one paragraph

Article in IET systems biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

K RadhakrishnanUniversity of New Mexico School of Medicine, Department of Pathology and Cancer Center, Albuquerque, NM, USA. kradhakrishnan@salud.unm.edu
J S Edwards
D S Lidke
T M Jovin
B S Wilson
J M Oliver
University of New Mexico · USNew Mexico Cancer Center · USMax Planck Institute for Biophysical Chemistry · DE

Funding

UNM TRAININGP50GM085273 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WANDINGER-NESS, ANGELA · 2009 to 2018
$26.1M
Mapping for Specialized Domains for FCeRI Signaling & InternalizationR01AI051575 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WILSON, BRIDGET S · 2003 to 2013
$3.3M
MSM Mapping and Modeling ErbB Receptor Membrane Topogra*R01CA119232 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WILSON, BRIDGET S · 2005 to 2012
$2.1M
TOPOGRAPHICAL MODELING OF FCRI /FPR SIGNALING PATHWAYSP20GM067594 · NIGMS · UNIVERSITY OF NEW MEXICO · PI OLIVER, JANET M · 2002 to 2007
$1.6M
NCI NIH HHS R01 CA119232NIAID NIH HHS R01 AI051575NIGMS NIH HHS P20 GM067594NIGMS NIH HHS P20GM067594NIGMS NIH HHS P50 GM085273
6 · The paper itself

Abstract

Following phosphorylation, nuclear translocation of the mitogen-activated protein kinases (MAPKs), ERK1 and ERK2, is critical for both gene expression and DNA replication induced by growth factors. ERK nuclear translocation has therefore been studied extensively, but many details remain unresolved, including whether or not ERK dimerisation is required for translocation. Here, we simulate ERK nuclear translocation with a compartmental computational model that includes systematic sensitivity analysis. The governing ordinary differential equations are solved with the backward differentiation formula and decoupled direct methods. To better understand the regulation of ERK nuclear translocation, we use this model in conjunction with a previously published model of the ERK pathway that does not include an ERK dimer species and with experimental measurements of nuclear translocation of wild-type ERK and a mutant form, ERK1-4, which is unable to dimerise. Sensitivity analysis reveals that the delayed nuclear uptake of ERK1-4 compared to that of wild-type ERK1 can be explained by the altered interaction of ERK1-4 with phosphorylated MEK (MAPK/ERK kinase), and so may be independent of dimerisation. Our study also identifies biological experiments that can verify this explanation.

Indexed as

Active Transport, Cell NucleusMAP Kinase Signaling SystemAnimalsComputer SimulationDimerizationMiceMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase KinasesModels, BiologicalMutant ProteinsMutationPhosphorylationSystems BiologyMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase KinasesMutant Proteins

Identifiers

PMID21028924
PMCPMC3097028
OpenAlexW1599378436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.